retatrutide latest clinical trial data Lilly's triple agonist achieves 16.8% weight loss in phase 3 trial

GLP-1 (7-36) amide | Sterile

21.41

★★★★☆5.0 (58)

New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our

23.48

★★★★★4.0 (242)

Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding

23.95

★★★★★4.2 (214)

FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of

27.15

★★★★★5.0 (134)

Buyer beware. New data points to a higher likelihood of adverse events from using compounded GLP-1 meds versus the fda approved branded versions. No I dong get paid by these companies. In fact the

25.32

★★★★★4.4 (236)

Weight loss drug cost: How much people are willing to spend

22.80

★★★★★4.2 (158)

GLP-1 Medications – FDA Guidance and Compounded Products

21.73

★★★★★4.6 (148)